Rugo, H. S., Jo Chien, A., Franco, S. X., Stopeck, A. T., Glencer, A., Lahiri, S., . . . Dickler, M. N. (2011). A phase II study of lapatinib and bevacizumab as treatment for HER2-overexpressing metastatic breast cancer. Springer US.
استشهاد بنمط شيكاغوRugo, Hope S., et al. A Phase II Study of Lapatinib and Bevacizumab As Treatment for HER2-overexpressing Metastatic Breast Cancer. Springer US, 2011.
MLA استشهادRugo, Hope S., et al. A Phase II Study of Lapatinib and Bevacizumab As Treatment for HER2-overexpressing Metastatic Breast Cancer. Springer US, 2011.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.